Parker Waichman LLP Headlines by Topic
Actonel
Health Canada Revises Bisphosphonate Labels with Fracture Warning
Dec 20, 2011
| Parker Waichman LLP
Health Canada has announced that its review of bisphosphonates has shown a slightly increased risk of atypical thigh fractures among people who use...
FDA Panel Calls for New Warnings on Bisphosphonates, But Not Specific Time Limits on Usage
Sep 12, 2011
| Parker Waichman LLP
A panel of outside medical experts was unable to recommend how long women can safely take oral bisphosphonates for osteoporosis, but did vote 17-6...
Bisphoshonate Benefits Plateau at Five Years, FDA Says
Sep 8, 2011
| Parker Waichman LLP
Women who take oral bisphosphonates such as Fosamax to prevent broken bones from osteoporosis may not have to take them beyond five years to get...
Fosamax, Bisphosphonates Face FDA Review
Sep 6, 2011
| Parker Waichman LLP
A U.S. Food & Drug Administration (FDA) advisory panel scheduled to meet on Friday could recommend that women taking Fosamax and other oral...
FDA: No Conclusion on Oral Bisphosphonate-Esophageal Cancer Link
Jul 21, 2011
| Parker Waichman LLP
The U.S. Food & Drug Administration (FDA) is reviewing a possible association between oral bisphosphonates and the development of esophageal...
Increased Vitamin D Might Make Bisphosphonates More Effective
Jun 9, 2011
| Parker Waichman LLP
Vitamin D supplementation might help bisphosphonates like Fosamax do a better job of protecting bones, a new study says. The study, conducted...
Bisphosphonate "Drug Holidays" Recommended to Reduce Thigh Fracture Risk
May 13, 2011
| Parker Waichman LLP
People taking bisphosphonates for osteoporosis, including Fosamax, should ask their doctors about a drug holiday, experts say. The...
Bisphosphonate Study Finds Link to Rare Thigh Fractures
May 5, 2011
| Parker Waichman LLP
Another study, this time out of Sweden, has found a link between bisphosphonates, such as Fosamax, and a rare type of thigh fracture in women....
Fosamax, Other Bone Drugs Being Reconsidered in Light of Side Effects
Nov 8, 2010
| Parker Waichman LLP
Some doctors are recommending that women take a break from Fosamax and other osteoporosis drugs known as bisphosphonates. The recommendations come...
Fosamax, Other Osteoporosis Drugs, Linked to Rare Thigh Fractures, FDA Warns
Oct 14, 2010
| Parker Waichman LLP
Bisphosphonates, a class of osteoporosis drugs that includes Fosamax, have been linked to two rare types of thigh fractures. According to the US...
